Difference between revisions of "Elafin (TG2)"
(New page: {{subst:infobox}}) |
m |
||
(9 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
− | |||
{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | ||
− | ! | + | ! {infobox header}| '''{{PAGENAME}}''' |
|- | |- | ||
− | | align="center" colspan="2" bgcolor="#ffffff" | [[Image: | + | | align="center" colspan="2" bgcolor="#ffffff" | [[Image:Elafin.JPG|200px|{{PAGENAME}}]] |
|- | |- | ||
| Substrate peptide name | | Substrate peptide name | ||
− | | | + | | Elafin |
|- | |- | ||
| Synonyms | | Synonyms | ||
− | | - | + | | Cementoin |
+ | Elastase-specific inhibitor | ||
|- | |- | ||
| Determination type | | Determination type | ||
− | | In situ | + | | In situ/In vitro |
|- | |- | ||
| Source | | Source | ||
Line 18: | Line 18: | ||
|- | |- | ||
| Subcellular localization | | Subcellular localization | ||
− | | | + | | Cornified evelope |
|- | |- | ||
| Swissprot ID | | Swissprot ID | ||
− | | [http://au.expasy.org/uniprot/ | + | | [http://au.expasy.org/uniprot/P19957 P19957 ] |
|- | |- | ||
| Reactive glutamines | | Reactive glutamines | ||
− | | [[ | + | | [[TG2 reactive residues (Elafin)|Q2 Q59]] |
|- | |- | ||
| Reactive lysines | | Reactive lysines | ||
− | | | + | | [[TG2 reactive residues (Elafin)|K6]] |
|- | |- | ||
| Substrate sequence | | Substrate sequence | ||
− | | | + | | A''Q''EPV''K''GPV |
+ | |||
+ | ACFVP''Q'' | ||
+ | |||
|- | |- | ||
| Structure | | Structure | ||
− | | [http://www.rcsb.org/pdb/explore/explore.do?structureId= | + | | [http://www.rcsb.org/pdb/explore/explore.do?structureId=2REL 2REL] |
|- | |- | ||
| Surface accessibility | | Surface accessibility | ||
− | | [http://gibk21.bse.kyutech.ac.jp/asaview/all/ | + | | [http://gibk21.bse.kyutech.ac.jp/asaview/all/2rel.pdf ASAView] pdf |
+ | [http://gibk21.bse.kyutech.ac.jp/asaview/all/2rel.txt ASAView] txt | ||
|- | |- | ||
| Disorder prediction | | Disorder prediction | ||
Line 42: | Line 46: | ||
|- | |- | ||
| Reference | | Reference | ||
− | | [http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids= | + | | [http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=7914520&dopt=Abstract PMID:7914520] |
|- | |- | ||
| Notes | | Notes | ||
| | | | ||
|- | |- | ||
− | | {{infobox header | + | | Video |
+ | |{{#ev:dailymotion|ot2lRay5hDTBDkXRI|300}} | ||
+ | |- | ||
+ | | {infobox header} | | ||
|- | |- | ||
|} | |} | ||
[[Category:Tissue transglutaminase|*]] | [[Category:Tissue transglutaminase|*]] |
Latest revision as of 11:33, 10 March 2015
Elafin (TG2) | |
---|---|
Substrate peptide name | Elafin |
Synonyms | Cementoin
Elastase-specific inhibitor |
Determination type | In situ/In vitro |
Source | Homo sapiens |
Subcellular localization | Cornified evelope |
Swissprot ID | P19957 |
Reactive glutamines | Q2 Q59 |
Reactive lysines | K6 |
Substrate sequence | AQEPVKGPV
ACFVPQ |
Structure | 2REL |
Surface accessibility | ASAView pdf
ASAView txt |
Disorder prediction | IUPred |
Reference | PMID:7914520 |
Notes | |
Video | ot2lRay5hDTBDkXRI|300}} |